| Literature DB >> 35697165 |
Yuzhe Huang1, Hao Chen1, Kunfeng Zhang1, Yongming Lu1, Qianzheng Wu1, Jielin Chen1, Yong Li1, Qingxi Wu1, Yan Chen2.
Abstract
Intestinal dysbiosis is one of the major causes of the occurrence of metabolic syndromes, such as obesity, diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Polysaccharide-based microbial therapeutic strategies have excellent potential in the treatment of metabolic syndromes, but the underlying regulatory mechanisms remain elusive. Identification of the internal regulatory mechanism of the gut microbiome and the interaction mechanisms involving bacteria and the host are essential to achieve precise control of the gut microbiome and obtain valuable clinical data. Polysaccharides cannot be directly digested; the behavior in the intestinal tract is considered a "bridge" between microbiota and host communication. To provide a relatively comprehensive reference for researchers in the field, we will discuss the polysaccharide extraction and purification processes and chemical and structural characteristics, focusing on the polysaccharides in gut microbiota through the immune system, gut-liver axis, gut-brain axis, energy axis interactions, and potential applications.Entities:
Keywords: Bioactivity; Chain conformation; Gut microbiota; Metabolic syndrome; Polysaccharides
Mesh:
Substances:
Year: 2022 PMID: 35697165 DOI: 10.1016/j.ijbiomac.2022.06.049
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953